2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
Pharmacology, Toxicology and Pharmaceutical Science
38
7%
Agricultural and Biological Sciences
18
3%
Biochemistry, Genetics and Molecular Biology
17
3%
Nursing and Health Professions
10
2%
Other
33
6%
Unknown
165
30%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 53. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 November 2024.
All research outputs
#1,022,542
of 34,575,175 outputs
Outputs from European Journal of Cancer (1965)
#161
of 8,863 outputs
Outputs of similar age
#4,059
of 250,889 outputs
Outputs of similar age from European Journal of Cancer (1965)
#1
of 56 outputs
Altmetric has tracked 34,575,175 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,863 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,889 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.
